Skip to main content
×
Home
    • Aa
    • Aa

Metabolic syndrome: what is it and what are the implications?

  • D. I. Shaw (a1), W. L. Hall (a1) and C. M. Williams (a1)
Abstract

Obesity and overweight are linked with a cluster of metabolic and vascular disorders that have been termed the metabolic syndrome. Although there is not yet a universally-accepted set of diagnostic criteria, most expert groups agree that the syndrome is characterised by impaired insulin sensitivity and hyperglycaemia, dyslipidaemia (elevated blood triacyglycerols with depressed HDL-cholesterol), abdominal obesity and hypertension. Based on existing published criteria estimates suggest that the syndrome affects a substantial percentage of the middle-aged and elderly populations of most European countries (10–20%) and confers increased risk of type 2 diabetes (2–8.8-fold) and CVD (1.5–6-fold), as well as having a marked effect on morbidity. Although the pathophysiology is incompletely understood, insulin resistance and abdominal obesity are central to subsequent abnormalities in circulating glucose and lipoproteins, and vascular function that lead to type 2 diabetes, atherosclerosis and CVD. The link between metabolic syndrome, type 2 diabetes and CVD, as well as inability to reverse the present rising rates of obesity, will lead to economically-unsustainable costs of health care in the next 10–20 years. Preventative strategies for metabolic syndrome are required to slow rates of progression and to reduce dependence on costly medical management. A notable development is recent evidence that shows that diet and exercise are more effective than drug treatment in preventing the development of type-2 diabetes in high-risk individuals. The LIPGENE project will investigate dietary fat quality as a strategy for the prevention of metabolic syndrome and identify food chain approaches that can support consumer attempts to alter their dietary patterns.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Metabolic syndrome: what is it and what are the implications?
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Metabolic syndrome: what is it and what are the implications?
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Metabolic syndrome: what is it and what are the implications?
      Available formats
      ×
Copyright
Corresponding author
*Corresponding author: Ms D. Shaw, fax + 44 118 9318703, d.i.shaw@reading.ac.uk
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

C Alexander , P Landsman , S Teutsch & S Haffner (2003) NCEP-defined metabolic syndrome, diabetes and the prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52, 12101214.

J Ascaso , P Romero , J Real , R Lorente , J Martinez-Valls & R Carmena (2003) Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. European Journal of Internal Medicine 14, 101106.

B Balkau , M Vernay , L Mhamdi , M Novak , D Arondel , S Vol , J Tichet & E Eshwege (2003) The incidence and persistence of the NCEP (National Cholesterol Education Progam) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metabolism 29, 526532.

E Bonora , S Kiechl , J Willeit , F Oberhollenzer , G Egger , R Bonadonna & M Muggeo (2003) Prevalence, ancillary clinical features and cardiovascular disease in the metabolic syndrome: the Bruneck study. International Congress Series 1253, 1317.

D Carr , K Utzschneider , R Hull , K Kodama , B Retzlaff , J Brunzell , J Shofer , B Fish , R Knopp & S Kahn (2004) Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53, 20872094.

W Chen , S Srinivasan , A Elkasabany & G Berenson (1999) The association of cardiovascular risk factor clustering related to insulin resistance syndrome (Syndrome X) between young parents and their offspring: the Bogalusa Heart Study. Atherosclerosis 145, 197205.

G Dowse & P Zimmet (1993) The thrifty genotype in non-insulin dependent diabetes. British Medical Journal 306, 532533.

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association 285, 24862497.

E Ford , W Giles & W Dietz (2002) Prevalence of the metabolic syndrome amongst US adults: findings from the Third National Health and Nutrition Examination Survey. Journal of the American Medical Association 287, 356359.

ES Ford (2004) The metabolic syndrome and mortality from cardiovascular disease and all causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 173, 309314.

S Grundy (2004a) Metabolic syndrome: Part I. Endocrinology and Metabolism Clinics of North America 33, ixxi.

S Grundy (2004b) Obesity, metabolic syndrome, and cardiovascular disease. Journal of Clinical Endocrinology and Metabolism 89, 22952600.

E Haber , H Ximenes , J Procopio , C Carvalho , R Curi & A Carpinelli (2002) Pleiotropic effects of fatty acids on pancreatic beta cells. Journal of Cellular Physiology 194, 112.

R Hanson , G Imperatore , P Bennett & W Knowler (2002) Components of the Metabolic Syndrome and incidence of type 2 diabetes. Diabetes 51, 31203127.

S Hills , B Balkau , S Coppack , J Dekker , A Mari , A Natali , M Walker & E Ferrannini (2004) The EGIR-RISC Study (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): 1. Methodology and objectives. Diabetologia 47, 566570.

G Hu , Q Qiao , J Tuomilehto , B Balkau , K Borch-Johnsen & K Pyorala (2004) Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Archives of Internal Medicine 164, 10661076.

B Isomaa , P Almgren , T Tuomi , B Forsen , K Lahti , M Nissen , M Taskinen & L Groop (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683689.

P James (2004) Obesity: The worldwide epidemic. Clinics in Dermatology 22, 276280.

R Kohen-Avramoglu , A Theriault & K Adeli (2003) Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidaemia. Clinical Biochemistry 36, 413420.

D Laaksonen , H Lakka , L Niskanen , G Kaplan , J Salonen & T Lakka (2002) Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. American Journal of Epidemiology 156, 10701077.

H Lakka , D Laaksonen , T Lakka , L Niskanen , E Kumpulsalo , J Tuomilehto & J Salonen (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Journal of the American Medical Association 288, 27092716.

T Lobstein , L Baur & R Uauy (2004) Obesity in children and young people: a crisis in public health. Obesity Reviews 5, 485.

S Malik , N Wong , S Franklin , T Kamath , G L'Italien , J Pio & R Williams (2004) Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110, 12451250.

P Nestel (2004) Nutritional aspects in the causation and management of the metabolic syndrome. Endocrinology and Metabolism Clinics of North America 33, 483492.

J Ninomiya , G L'Italien , M Criqui , J Whyte , A Gamst & R Chen (2004) Association of the metabolic syndrome with history of myocardial infarction and stroke in the third national health and nutrition examination survey. Circulation 109, 4246.

L Palaniappan , M Carnethon , Y Wang , A Hanley , S Fortmann , S Haffner & L Wagenknecht (2004) Predictors of the incident metabolic syndrome in adults. Diabetes Care 27, 788793.

D Panagiotakos , C Pitsavos , C Chrysohoou , J Skoumas , D Tousoulis , M Toutouza , P Toutouzas & C Stefanadis (2004) Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. American Heart Journal 147, 106112.

GM Reaven (1988) Role of insulin resistance in human disease. Diabetes 37, 15951600.

H Resnick , K Jones , G Ruotolo , A Jain , J Henderson , W Lu & B Howard (2003) Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians. Diabetes Care 26, 861867.

A Scuteri , SS Najjar , DC Muller , R Andres , H Hougaku , EJ Metter & EG Lakatta (2004) Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. Journal of the American College of Cardiology 43, 13881395.

C Tan , S Ma , D Wai , S Chew & E Tai (2004) Can we apply the National Cholesterol Education Program Treatment Panel definition of the metabolic syndrome to Asians. Diabetes Care 27, 11821186.

B Vessby , M Uusitupa , K Hermansen , G Riccardi , A Rivellese , L Tapsell (2001) Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study. Diabetologia 44, 312319.

R Weiss , J Dzlura , T Burgert , W Tamborlane , S Taksali , C Yeckel (2004) Obesity and the metabolic syndrome in children and adolescents. New England Journal of Medicine 350, 23622374.

P Wilson (2004) Estimating cardiovascular disease risk and the metabolic syndrome: a Framingham view. Endocrinology and Metabolism Clinics of North America 33, 467481.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Proceedings of the Nutrition Society
  • ISSN: 0029-6651
  • EISSN: 1475-2719
  • URL: /core/journals/proceedings-of-the-nutrition-society
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 44 *
Loading metrics...

Abstract views

Total abstract views: 84 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 23rd May 2017. This data will be updated every 24 hours.